The high-affinity human IgG receptor Fc gamma receptor i (FcγRI) is not associated with vascular leakage of dengue

Journal of Negative Results in BioMedicine

Volumn 14, Issue 1, 2015, Pages

  Zamberi, Zaiharina Mohamad ^a   Zakaria, Zuraihan ^a   Aziz, Abu Thalhah Abdul ^a   Heng, Benedict Sim Lim ^b   Zaid, Masliza ^b   Chong, Christopher Lee Kwok ^b   Noor, Fadzilah Mohd ^a   Bakar, Sazaly Abu ^c   Peng, Hoh Boon ^a  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^b HOSPITAL SUNGAI BULOH   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Dengue; ELISA; Fc RI; Vascular leakage

Indexed keywords

ANTIBODY; FC RECEPTOR; FC RECEPTOR I; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FCGR1A PROTEIN, HUMAN;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEROLOGY; SYMPTOM; VASCULAR DISEASE; VASCULAR LEAKAGE; BLOOD; COHORT ANALYSIS; VASCULAR SYSTEM INJURIES; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CHILD; COHORT STUDIES; DENGUE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, IGG; VASCULAR SYSTEM INJURIES; YOUNG ADULT;

EID: 85017331089     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/s12952-014-0020-6     Document Type: Article

References (32)

1. World Health Organization. WHO Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: 2009.
2. iDengue for Community. http://idengue.remotesensing.gov.my/idengue/index.php.
3. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009;22:564-81.
4. World Health Organization. WHO Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Geneva: 2007.
5. Senanayake S. Dengue fever and dengue hemorrhagic fever - a diagnostic challenge. Aust Fam Physician. 2006;35:609-12.
6. Huerta-Zepeda A, Cabello-Gutierrez C, Cime-Castillo J, Monroy-Martinez V, Manjarrez-Zavala ME, Gutierrez-Rodriguez M, et al. Crosstalk between coagulation and inflammation during dengue virus infection. Thromb Haemost. 2008;99:936-43.
7. Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med. 1970;42:311-28.
8. Halstead SB, Porterfield JS, O'Rourke EJ. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg. 1980;29:638-42.
9. Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1997;146:201-17.
10. Kliks S. Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness. AIDS Res Hum Retroviruses. 1990;6:993-8.
11. Pang T, Cardosa MJ, Guzman MG. Of cascades and perfect storms: the immunopathogenesis of dengue hemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol. 2007;85:43-5.
12. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480-96.
13. Barnes N, Gavin AL, Tan PS, Mottram P, Koetgen F, Hogarth PM. Fc gamma RI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity. 2002;16:379-89.
14. Nimmerjahn F, Ravetch JV. Fc gamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34-47.
15. Chawla T, Chan KR, Zhang SL, Tan HC, Lim APC, Hanson BJ, et al. Dengue virus neutralization in cells expressing Fc gamma receptors. PLoS One. 2013;8(5):e65231.
16. Noisakran S, Perng GC. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection. Exp Biol Med. 2008;233:401-8.
17. Ministry of Health. Clinical Practice Guideline: Management of Dengue Infection in Adult. Second ed. Malaysia: 2008.
18. Ranjit S, Kisson N, Jayakumar I. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol. Pediatr Crit Care Med. 2005;6:6.
19. Libraty DH, Young PR, Pickeng D, Endy TP, Kalayanarooj S, Green S, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002;186:1165-8.
20. Sa-Ngasang A, Anantapreecha S, A-Nuegoonpipat A, Chanama S, Wibulwattanakij S, Pattanakul K, et al. Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay. Epidemiol Infect. 2006;134:820-5.
21. Sang CT, Cuzzubbo AJ, Devine PL. Evaluation of a commercial capture enzyme-linked immunosorbent assay for detection of immunoglobulin M and G antibodies produced during dengue infection. Clin Diagn Lab Immunol. 1998;5:7-10.
22. Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, Kneen R, et al. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg. 1999;60:693-8.
23. Fanciulli M, Vyse TJ, Aitman TJ TJ. Copy number variation of Fc gamma receptor genes and disease predisposition. Cytogenet Genome Res. 2008;123:161-8.
24. Indik ZK, Park JG, Hunter S, Schreiber AD. The molecular dissection of Fc gamma receptor mediated phagocytosis. Blood. 1995;86:4389-99.
25. Ioan-Facsinay A, de Kimpe ASJ, Hellwig SM, van Lent PL, Hofhuis FM, van Ojik HH, et al. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity. 2002;16:391-402.
26. Holl V, Hemmerter S, Burrer R, Schmidt S, Bohbot A, Aubertin AM, et al. Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages. J Immunol. 2004;173:6274-83.
27. Nimmerjahn F, Ravetch JV. Review Fcg receptors: old friends and new family members. Immunity. 2006;24:19-28.
28. Loke H, Bethell D, Phuang CX, Day N, White N, Farrar J, et al. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the Vitamin D receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg. 2002;67:102-6.
29. Kontny U, Kurane I, Ennis FA. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol. 1998;62:3928-33.
30. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet. 2012;380:1559-67.
31. Lam SK, Devi S, Pang T. Detection of specific IgM in dengue infections. Southeast Asian J Trop Med Public Health. 1987;18:532-8.
32. Cordeiro MT, Braga-Neto U, Nogueira RM, Marques Jr ET. Reliable classifier to differentiate primary and secondary acute dengue infection baseed on IgG ELISA. PLoS One. 2009;4:e4945.